Shenzhen Mindray Bio-Medical Electronics revenue and financials
¥161.32Change from previous close: +1.45%Absolute change: +¥2.31
In the fiscal year ended December 2025, Shenzhen Mindray Bio-Medical Electronics reported revenue of ¥33.28B (−9.38% year over year). Net income was ¥8.14B, a net margin of 24.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −9.38%
- 2025 vs 2024
- Net income growth
- −30.28%
- 2025 vs 2024
- Net margin
- 24.4%
- 2024: 31.8%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 33,282 | 36,726 | 34,932 | 30,366 |
| Cost of revenue | 13,208 | 13,548 | 12,513 | 10,885 |
| Gross profit | 20,074 | 23,178 | 22,419 | 19,480 |
| Selling, general and administrative | 1,801 | 1,722 | 2,284 | 2,031 |
| Research and development | 3,579 | 3,666 | 3,433 | 2,923 |
| Operating income | 9,938 | 13,050 | 12,917 | 10,668 |
| EBIT | 9,698 | 13,039 | 13,024 | 10,964 |
| EBITDA | 11,419 | 14,508 | 14,034 | 11,849 |
| Interest expense | 24.0 | 19.4 | 13.0 | 10.7 |
| Pre-tax income | 9,674 | 13,020 | 13,011 | 10,954 |
| Income tax | 1,222 | 1,280 | 1,433 | 1,343 |
| Net income | 8,136 | 11,668 | 11,582 | 9,607 |
| Net income to common shareholders | 8,136 | 11,668 | 11,582 | 9,607 |
| Basic EPS | 6.71 | 9.64 | 9.56 | 7.94 |
| Diluted EPS | 6.71 | 9.63 | 9.56 | 7.94 |
| Average shares (basic) | 1,212 | 1,211 | 1,212 | 1,210 |
| Average shares (diluted) | 1,212 | 1,211 | 1,212 | 1,210 |